Carole Shardlow
GlaxoSmithKline (United Kingdom)(GB)University of Manchester(GB)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms, Drug Solubulity and Delivery Systems, Analytical Methods in Pharmaceuticals, Neurotransmitter Receptor Influence on Behavior
Most-Cited Works
- → IMI – Oral biopharmaceutics tools project – Evaluation of bottom-up PBPK prediction success part 2: An introduction to the simulation exercise and overview of results(2016)66 cited
- → Pharmacokinetics of the novel, high-affinity and selective dopamine D3 receptor antagonist SB-277011 in rat, dog and monkey:in vitro/in vivocorrelation and the role of aldehyde oxidase(2001)63 cited
- → IMI – Oral biopharmaceutics tools project – Evaluation of bottom-up PBPK prediction success part 3: Identifying gaps in system parameters by analysing In Silico performance across different compound classes(2016)45 cited
- → Impact of Physiologically Based Pharmacokinetic Modeling and Simulation in Drug Development(2013)40 cited
- → Coformulation of a Novel Human α -Galactosidase A With the Pharmacological Chaperone AT1001 Leads to Improved Substrate Reduction in Fabry Mice(2015)36 cited
- → Utilizing Drug-Drug Interaction Prediction Tools during Drug Development: Enhanced Decision Making Based on Clinical Risk(2011)33 cited